Rifampin 150 VP/015 (Rifampin 150 mg)
Pill imprint Rifampin 150 VP/015 has been identified as Rifampin 150 mg.
Rifampin is used in the treatment of bartonellosis; tuberculosis, latent; mycobacterium avium-intracellulare, treatment; endocarditis; haemophilus influenzae prophylaxis (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifampin 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- Rifampin 150 VP/015
- Strength:
- 150 mg
- Color:
- Red
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Rifamycin derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- VersaPharm Inc
- National Drug Code (NDC):
- 61748-0015
- Inactive Ingredients:
- lactose monohydrate
sodium lauryl sulfate
magnesium silicate
corn starch
silicon dioxide
magnesium stearate
ammonia
isopropyl alcohol
butyl alcohol
shellac
propylene glycol
dimethicone
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 40
gelatin
More about rifampin
Consumer resources
- Rifampin
- Rifampin capsules
- Rifampin Intravenous (Advanced Reading)
- Rifampin Oral, Intravenous (Advanced Reading)
- Other brands: Rifadin, Rimactane, Rifadin IV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
